English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/116620
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Lynch syndrome diagnostics: decision-making process for germ-line testing

AuthorsLastra, Enrique; García-González, María; Llorente, Beatriz; Bernuy, Coralina; Barrio, M. Jesús; Pérez-Cabornero, Lucía ; Durán, Mercedes ; García-Girón, Carlos
KeywordsLynch syndrome
Molecular diagnostics
Decision-making process
Germ-line testing
Issue Date2012
PublisherSpringer
CitationClinical and Translational Oncology 14(4): 254-262 (2012)
AbstractCancer risks and medical management of Lynch syndrome (LS) differ from other hereditary or familial clustering of colorectal cancer. Differential diagnosis has improved as a result of the growing clinical and molecular knowledge about LS. Appropriate application of these advances in several scenarios constitutes a decision-making process to further decide germ-line testing with accuracy and efficiency. However, an only molecular-screening algorithm, with a limited number of steps and choices, may be difficult to devise. How, when, where and at what expense to use the different diagnostic tools remain dynamic and changeable under different circumstances. From a clinical point of view, it is advisable to discuss conflicting aspects to guide LS diagnosis.
URIhttp://hdl.handle.net/10261/116620
DOI10.1007/s12094-012-0793-3
Identifiersdoi: 10.1007/s12094-012-0793-3
issn: 1699-048X
e-issn: 1699-3055
Appears in Collections:(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.